Łuksza, M., Sethna, Z. M., Rojas, L. A., Lihm, J., Bravi, B., Elhanati, Y., . . . Balachandran, V. P. (2022). Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Nature (London), 606(7913), 389-395. https://doi.org/10.1038/s41586-022-04735-9
Chicago Style (17th ed.) CitationŁuksza, Marta, et al. "Neoantigen Quality Predicts Immunoediting in Survivors of Pancreatic Cancer." Nature (London) 606, no. 7913 (2022): 389-395. https://doi.org/10.1038/s41586-022-04735-9.
MLA (9th ed.) CitationŁuksza, Marta, et al. "Neoantigen Quality Predicts Immunoediting in Survivors of Pancreatic Cancer." Nature (London), vol. 606, no. 7913, 2022, pp. 389-395, https://doi.org/10.1038/s41586-022-04735-9.
Warning: These citations may not always be 100% accurate.